A Multi-Center, Double-Blind, Placebo-Controlled Investigation of Silodosin in the Treatment of Subjects With Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Phase of Trial: Phase II
Latest Information Update: 23 Feb 2012
At a glance
- Drugs Silodosin (Primary)
- Indications Prostatitis
- Focus Therapeutic Use
- 17 May 2011 Results have been presented at AUA-2011 according to Watson Pharmaceuticals media release. Results were also reported in the media release.
- 13 May 2011 Results published in the Journal of Urology.
- 04 Nov 2009 Actual patient number (153) added as reported by ClinicalTrials.gov.